Disparities in colorectal cancer screening: A guideline-based analysis of adherence

Ethnicity and Disease

Volumn 16, Issue 1, 2006, Pages 228-233

  James, Tamarra M ^a   Greiner, K Allen ^b,c   Ellerbeck, Edward F ^b,c   Feng, Changyong ^d   Ahluwalia, Jasjit S ^e  

^a Mailman School of Public Health ^*  (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e University of Minnesota   (United States)

Author keywords

Cancer screening; Colonoscopy; Colorectal cancer; Fecal occult blood test; Proctoscopy; Sigmoidoscopy

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; ETHNICITY; EUROPEAN AMERICAN; FAMILY HISTORY; FECES ANALYSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OCCULT BLOOD; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; PRACTICE GUIDELINE; RACE DIFFERENCE; RECTOSCOPY; SEX DIFFERENCE; SIGMOIDOSCOPY; SOCIOECONOMICS; CAUCASIAN; COLORECTAL TUMOR; INTERVIEW; MIDDLE AGED; RISK; UTILIZATION REVIEW;

AFRICAN AMERICANS; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GUIDELINES; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; OCCULT BLOOD; ODDS RATIO; SIGMOIDOSCOPY;

EID: 33744984584     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53(1):5-26.
2. Selby J, Friedman G, Quesenberry C, Weiss N. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326(10):653-657.
3. Newcomb P, Norfleet R, Storer G, Surawicz T, Marcus P. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84(20):1572-1575.
4. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603-1607.
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomized study of screening for colorectal cancer with fecal-occult-blood test. Lancet. 1996;348(9040):1467-1471.
6. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomized controlled trial of fecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472-1477.
7. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365-1371.
8. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med. 1995;123(12):904-910.
9. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329(27):1977-1981.
10. Screening for colorectal cancer - United States, 1992-1993, and new guidelines. Morb Mortal Wkly Rep. 1996;45(5):107-110.
11. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001;93(22):1704-1713.
12. Nadel MR, Blackman DK, Shapiro JA, Seeff LC. Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Prev Med. 2002;35(3):199-206.
13. Ko CW, Kreuter W, Baldwin LM. Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med. 2002;162(22):2581-2586.
14. Seeff LC, Shapiro JA, Nadel MR. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System. J Fam Pract. 2002;51(9):761-766.
15. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003:97(6):1528-1540.
16. Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr. Cancer statistics by race and ethnicity. CA Cancer J Clin. 1998;48(1):31-48.
17. Freeman HP, Alshafie TA. Colorectal carcinoma in poor Blacks. Cancer. 2002;94(9):2327-2332.
18. Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. The late-stage diagnosis of colorectal cancer: demographic and socioeconomic factors. Am J Public Health. 1996;86(12):1794-1797.
19. Chao A, Gilliland FD, Hunt WC, Bulterys M, Becker TM, Key CR. Increasing incidence of colon and rectal cancer among Hispanics and American Indians in New Mexico (United States), 1969-94. Cancer Causes Control. 1998;9(2):137-144.
20. National Center for Health Statistics (NCHS). National Health Interview Survey. Hyattsville, Md: NCHS; 2000.
21. Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin. 1997;47(3):154-160.
22. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001 - testing for early lung cancer detection. CA Cancer J Clin. 2001;51(1):38-75; quiz 77-80.
23. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112(2):594-642.
24. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89(19):1406-1422.
25. Myers RE, Ross E, Jepson C, et al. Modeling adherence to colorectal cancer screening. Prev Med. 1994;23(2):142-151.
26. Myers RE, Wolf TA, McKee L, et al. Factors associated with intention to undergo annual prostate cancer screening among African-American men in Philadelphia. Cancer. 1996;78(3):471-479.
27. Myers RE, Vernon SW, Tilley BC, Lu M, Watts BG. Intention to screen for colorectal cancer among White male employees. Prev Med. 1998;27(2):279-287.
28. Myers RE, Chodak GW, Wolf TA, et al. Adherence by African-American men to prostate cancer education and early detection. Cancer. 1999;86(1):88-104.
29. Marcella S, Miller JE. Racial differences in colorectal cancer mortality: the importance of stage and socioeconomic status. J Clin Epidemiol. 2001;54:359-366.
30. Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. The late-stage diagnosis of colorectal cancer: demographic and socioeconomic factors. Am J Public Health. 1996;86(12):1794-1797.
31. Freeman HP, Alshafie TA. Colorectal carcinoma in poor Blacks. Cancer. 2002;94:2327-2332.
32. Hawley ST, Chang S, Risser D, Zhang Q. Colorectal cancer incidence and mortality in Texas 1990-1992: a comparison of rural classifications. J Rural Health. 2002;18(4):536-546.
33. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95(17):1276-1299.
34. Breen NL, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001;93(22):1704-1713.
35. Holmes-Rovner M, Williams GA, Hoppough S, Quillan L, Butler R, Given CW. Colorectal cancer screening barriers in persons with low income. Cancer Pract. 2002;10(5):240-247.
36. Nadel MR, Blackman DK, Shapiro JA, Seeff LC. Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Prev Med. 2002;35(3):199-206.
37. Walsh JME, Posner SF, Perez-Stable EJ. Colon cancer screening in the ambulatory setting. Prev Med. 2002;35:209-218.
38. Iezzoni LI, McCarthy EP, Davis RB, Harris-David L, O'Day B. Use of screening and preventive services among women with disabilities. Am J Med Qual. 2001;16(4):135-144.
39. Tang TS, Solomon LJ, McCracken LM. Barriers to fecal occult blood testing and sigmoidoscopy among older Chinese-American women. Cancer Pract. 2001;9(6):277-282.
40. James AS, Campbell MK, Hudson MA. Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina. Cancer Epidemiol Biomarkers Prev. 2002;11:529-534.
41. Blair KA. Cancer screening of older women: a primary care issue. Cancer Pract. 1998;6(4):217-222.
42. Baier M, Calonge N, Cutter G, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2000;9:229-232.
43. Madlensky L, McLaughlin J, Goel V. A comparison of self-reported colorectal cancer screening with medical records. Cancer Epidemiol Biomarkers Prev. 2003;12(7):656-659.
44. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003;53(1):27-43.